🔥🔥 Delighted to share our paper on ‘prehabilitation’ using Impella 5.5 & sharing our PT protocol
@IsmaelSalasMD
@amanda_acnp
@juanemarcano
@MDSachinKumar
et al.
Grateful to work with an amazing team of Surgeons, Cardiologists, ICU & PT team. 🙌🫀🫁
👉
Another win for GDMT.
Young guy with newly diagnosed EF 25% with dilated LV in April. Started on GDMT, able to push full dose entresto, coreg 12.5 bid, aldactone 25 and Farxiga for atleast 5 months. Echo today shows EF 50% with LV 5.8 cm.
#GDMTWorks
Great things happen, when women support women!
Big Thanks
@JCardFail
for sharing the vision, mission and future directions of
@Womenintxp_mcs
Incredibly fortunate to be a part of this network.
Gratitude to senior leaders for spearheading this to create opportunities for all.
🔥🔥Pragmatic & novel approach to define
#SCAI
shock stages using consistent & uniform definitions of hypotension and hypoperfusion.
🔥Simple & accessible bedside parameters- on admission and throughout hosp for CS by
#CSWG
registry using High yield data in
@JACCJournals
⭐️ Not revascularizing a revascularizable HF patient is not an option
⭐️ Support, unload and then revascularize
Surgical turndown linked with poor outcomes
Dr
@NavinKapur4
discusses rationale for revascularization in
#HF
#HFSA2021
Help TCACC welcome
@KTamirisaMD
as your Governor-Elect! 🫀🩺 Dr. Tamirisa has already served in leadership roles for our organization as one of the co-chairs for the EP section. We’re proud to have Dr. Tamirisa as a TCACC leader and look forward to continued collaboration! 👏
Gender distribution in editorial boards in IM & Cardiology journals- brilliantly presented by Prisha Shivani a HIGH SCHOOL student from
@phillipsacademy
#AHA2023
@NutritionHF
Save the date as you plan to join us for our next Shock Symposium
#HSS
📍Houston
📆 Apr 14-16, 2023
@HoustonShockHSS
🏷 Learn everything new on
#CardiogenicShock
🏷 Share your science, cases
🏷 Networking with Shock Leaders
🏷 State of the art hands on skills lab
🏷 CME
We are beyond thoughts and prayers!! Never put anything political on my Twitter but this isn’t political anymore.
It’s inhuman to stay silent on loss of 14 young lives..
#Policychange
Grateful to be a part of the Cardiac Amyloidosis Registry Study (CARS): largest multicenter registry of diverse
#CardiacAmyloid
pts (both AL & ATTR) in US.
Read the Rationale/design paper headlined by
@LilySternMD
@JigPatelMDPhD
@MKIttlesonMD
et al
👉
Join HFSA Women in HF committee January 26, 6-7 pm ET as they discuss an investigation in
@JAMACardio
- Gender Differences in Medicare Payments Among Cardiologists. Tweet your comments and questions by following
#WomenInHFJC
and
@docbhardwaj
,
@SBeukian
, and
@ersied727
to join in!
Great things happen when we learn from each other. Thanks to all attendees
#HSS23
@HoustonShockHSS
Juggling b/w work & conference this weekend reinforced my why! 🙏
Let’s keep working together for our patients
#WarOnShock
💫And making lifelong friends on the way is a bonus.
It’s a wrap! Thank you to our attendees, faculty,
@CardioNerds
scholars, and industry partners for their pivotal role in breaking boundaries at
#HSS23
!
The sessions will be available for viewing at (shock library).
See you all at
#HSS24
!
@JumeanMarwan
Stellar talk by
@preventfailure
on variability across implanting centers for mortality and AEs in HM3 population
@manreetkanwar
#ISHLT2022
🏷 Look beyond the design, improve outcomes
🏷 Regular Program quality assessment
🏷 Guidelines for standardized excellence
Terrific talk by my stellar friend
@AminYehyaMD
on clinical outcomes & survival of HIV+/- patients using largest STS-INTERMACS data .
#ISHLT2022
@ISHLT
🏷 similar survival despite ⬆️ comorbidities
🏷 carefully selected patients should be considered for
#LVAD
Importance of Sex Disaggregated Data in
#HF
Clinical Trials: Where Are We in 2022?siac
👉 Both 🙋♂️🙋♀️ must be represented in % to the sex distribution of disease
👉sex-specific recommendations in clinical guidelines
👉sex-specific subgroup analyses into analytic plan of HF trials